Zurletrectinib Shows Strong Activity Against NTRK Fusion-Positive Tumors
30 Jul 2024 //
BUSINESSWIRE
InnoCare Announces First Pediatric Patient Dosed in Trial of Zurletrectinib
23 Jan 2024 //
BUSINESSWIRE
30 Jul 2024 //
BUSINESSWIRE
23 Jan 2024 //
BUSINESSWIRE